Mylan and Biocon to present phase-III trastuzumab biosimilar data at ASCO annual meeting HERITAGE study shows comparable efficacy, safety and immunogenicity to branded trastuzumab in HER2-positive metastatic breast cancer patients June 6, 2016 14:26 IST
Delhi HC refrains from staying single judge interim order over breast cancer drug by Biocon and Mylan The division bench of the high court, however, said the drug-makers may continue to sell their products under the brand… April 29, 2016 10:49 IST
Mylan Health Hackathon to host health hackathon in Bengaluru The event will focus on better health for a better world Mylan will host a health hackathon at its Global… March 10, 2016 10:55 IST
Mylan acquires certain women healthcare businesses from Famy Care To create a leading Women’s Healthcare Franchise November 20, 2015 20:09 IST
Govt clears Mylan’s takeover of Jai Pharma With this approval, FDI of $750 million will be received in the country The government has approved the proposal of… November 6, 2015 16:24 IST
Biocon-Mylan programmes make clinical progress PEG-G-CSF and Adalimumab enter phase II while patient recruitment for one insulin Glargine phase II study is complete Biocon has… May 7, 2015 11:10 IST
Mylan rejects Teva’s $40 bn offer as ‘gross undervaluation’ Mylan has rejected a US dollar 40 billion unsolicited merger offer from Israel’s Teva Pharmaceutical Industries. April 28, 2015 15:28 IST
Mylan rejects Teva’s $40 bn offer as ‘gross undervaluation’ Says, “bringing Teva’s ‘dysfunctional’ culture to the region (India) could disrupt the core of its business, result in the flight… April 28, 2015 15:16 IST
Teva bid opens $2 bn window for Indian pharma Mylan On Tuesday, Israel-based pharma company Teva announced an unsolicited offer to buy Mylan… April 23, 2015 00:31 IST
Mylan to acquire Famy Care to create women’s healthcare franchise This transaction especially complements Mylan’s pending acquisition of Abbott’s non-US developed markets speciality and branded generics business Updated: February 4, 2015 14:16 IST
Mylan buys female health businesses from Indian drugmaker Mylan Inc said it would buy Indian drugmaker Famy Care Ltd’s female health businesses for about $750 million… Updated: February 2, 2015 19:36 IST
There is no workforce better than India’s: Rajiv Malik, Mylan Mylan is the world’s second-largest generic drug player in terms of revenue. December 4, 2014 03:59 IST
Adani Transmission, Adani Total Gas shares tank up to 3% as scrips exit MSCI Global Standard Index today
10 Photos IPL 2023: CSK’s glorious win over GT, Dhoni’s heart-breaking retirement remark – This Finale had it all! See Photos 23 hours agoMay 30, 2023
6 Photos Colourful lights, laser show illuminate new Parliament building – See Stunning Photos 2 days agoMay 29, 2023
8 Photos Forceful end to protest? Wrestlers trying to march to new Parliament detained by Delhi Police | See Photos 3 days agoMay 28, 2023
